Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Pathology and Clinical Laboratory Medicine, |
RCV001824217 | SCV002073832 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV001824217 | SCV003566435 | uncertain significance | not specified | 2021-07-09 | criteria provided, single submitter | clinical testing | The c.1304C>T (p.T435I) alteration is located in exon 12 (coding exon 11) of the MBD1 gene. This alteration results from a C to T substitution at nucleotide position 1304, causing the threonine (T) at amino acid position 435 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004710386 | SCV005250802 | benign | not provided | criteria provided, single submitter | not provided |